5-Lipoxygenase gene expression in hemodialysis

Artif Organs. 1998 Feb;22(2):140-2. doi: 10.1046/j.1525-1594.1998.06047.x.

Abstract

Leukotrienes (LTs), the end products of the eicosanoid pathway released during inflammation, are markers of polymorphonuclear cell and monocyte activation. The present study focused on the possibility that 5-lipoxygenase (5-LO), the key enzyme for LT synthesis, was involved in the interaction between blood and the hemodialysis (HD) membrane. 5-LO gene expression was examined by reverse transcriptase polymerase chain reaction (RT-PCR) in samples of mononuclear cells isolated from peripheral blood withdrawn at the start and at 15 min of HD from 10 chronic HD patients, 5 treated with Cuprophan and 5 with polymethylmethacrylate (PMMA) membrane. An increased 5-LO gene expression was detected at 15 min in 4 of 5 patients using the Cuprophan membrane but in none of the 5 PMMA treated patients. Our results showed for the first time that the interaction between blood and the HD membrane upregulates 5-LO messenger ribonucleic acid (mRNA).

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arachidonate 5-Lipoxygenase / genetics*
  • Arachidonate 5-Lipoxygenase / metabolism
  • Cellulose / analogs & derivatives
  • Cellulose / chemistry
  • Cellulose / metabolism
  • Female
  • Gene Expression Regulation, Enzymologic / genetics*
  • Humans
  • Leukocytes, Mononuclear / enzymology
  • Leukotrienes / biosynthesis
  • Male
  • Membranes, Artificial*
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymethyl Methacrylate / chemistry
  • Polymethyl Methacrylate / metabolism
  • RNA, Messenger / metabolism
  • Renal Dialysis*
  • Renal Insufficiency / therapy
  • Up-Regulation / genetics

Substances

  • Leukotrienes
  • Membranes, Artificial
  • RNA, Messenger
  • Cellulose
  • Polymethyl Methacrylate
  • cuprammonium cellulose
  • Arachidonate 5-Lipoxygenase